Page last updated: 2024-10-24

1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine and Burkitt Lymphoma

1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine has been researched along with Burkitt Lymphoma in 1 studies

1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine: biologically active analog of PAF; structure given in first source

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Travers, JB1
Li, Q1
Sprecher, H1
Fertel, RH1

Other Studies

1 other study available for 1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine and Burkitt Lymphoma

ArticleYear
Binding of carbamyl-platelet-activating factor to the Raji lymphoblast platelet-activating factor receptor.
    International journal of immunopharmacology, 1992, Volume: 14, Issue:4

    Topics: Burkitt Lymphoma; Humans; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycopr

1992